Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Direct stenting with the Bx VELOCITY balloon-expandable stent mounted on the Raptor rapid exchange delivery system versus predilatation in a European randomized Trial: the VELVET trial.
Serruys PW, IJsselmuiden S, Hout Bv, Vermeersch P, Bramucci E, Legrand V, Pieper M, Antoniucci D, Gomes RS, Macaya C, Boekstegers P, Lindeboom W; VELVET investigators. Serruys PW, et al. Among authors: pieper m. Int J Cardiovasc Intervent. 2003;5(1):17-26. doi: 10.1080/14628840304607. Int J Cardiovasc Intervent. 2003. PMID: 12623561 Free article. Clinical Trial.
Clinical and angiographic results with the beStent: the Registry for Optimal beStent Evaluation (ROSE) trial.
Suryapranata H, Boland JL, Pieper M, Legrand VL, Bonnier JJ, Juliard JM, Vrolix MC, Seabra-Gomes R, Hamburger JN, Roguin A, Oosterwijk C, Van Es GA, Beyar R, Serruys PW. Suryapranata H, et al. Among authors: pieper m. Int J Cardiovasc Intervent. 2000 Mar;3(1):21-28. doi: 10.1080/14628840050516271. Int J Cardiovasc Intervent. 2000. PMID: 12470383
Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS).
Urban P, Macaya C, Rupprecht HJ, Kiemeneij F, Emanuelsson H, Fontanelli A, Pieper M, Wesseling T, Sagnard L. Urban P, et al. Among authors: pieper m. Circulation. 1998 Nov 17;98(20):2126-32. doi: 10.1161/01.cir.98.20.2126. Circulation. 1998. PMID: 9815866 Clinical Trial.
A prospective randomized trial comparing stenting to internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis: the SIMA trial. Stenting vs Internal Mammary Artery.
Goy JJ, Kaufmann U, Goy-Eggenberger D, Garachemani A, Hurni M, Carrel T, Gaspardone A, Burnand B, Meier B, Versaci F, Tomai F, Bertel O, Pieper M, de Benedictis M, Eeckhout E. Goy JJ, et al. Among authors: pieper m. Mayo Clin Proc. 2000 Nov;75(11):1116-23. doi: 10.4065/75.11.1116. Mayo Clin Proc. 2000. PMID: 11075740 Clinical Trial.
10-year follow-up of a prospective randomized trial comparing bare-metal stenting with internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis the SIMA (Stenting versus Internal Mammary Artery grafting) trial.
Goy JJ, Kaufmann U, Hurni M, Cook S, Versaci F, Ruchat P, Bertel O, Pieper M, Meier B, Chiarello L, Eeckhout E; SIMA Investigators. Goy JJ, et al. Among authors: pieper m. J Am Coll Cardiol. 2008 Sep 2;52(10):815-7. doi: 10.1016/j.jacc.2008.05.037. J Am Coll Cardiol. 2008. PMID: 18755343 Free article. Clinical Trial.
Percutaneous transluminal therapy of occluded saphenous vein grafts: can the challenge be met with ultrasound thrombolysis?
Rosenschein U, Gaul G, Erbel R, Amann F, Velasguez D, Stoerger H, Simon R, Gomez G, Troster J, Bartorelli A, Pieper M, Kyriakides Z, Laniado S, Miller HI, Cribier A, Fajadet J. Rosenschein U, et al. Among authors: pieper m. Circulation. 1999 Jan 5-12;99(1):26-9. doi: 10.1161/01.cir.99.1.26. Circulation. 1999. PMID: 9884375 Clinical Trial.
Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study.
Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Baldus S, Hauptmann KE, Suttorp MJ, Drzewiecki J, Pieper M, Schultheiss HP, Mauri L. Fajadet J, et al. Among authors: pieper m. EuroIntervention. 2010 Nov;6(5):562-7. doi: 10.4244/EIJV6I5A95. EuroIntervention. 2010. PMID: 21044908
204 results